KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Theorem Clinical Research, a leading contract research organization, announced that Jason Monteleone, senior vice president and chief financial officer, will present during the Finance in Pharma and Healthcare Summit May 15-16 in Philadelphia.
Monteleone will present “Being David in an Industry of Goliaths” at 11:30 a.m. May 16. During his presentation, Monteleone will address how midsized contract research organizations (CROs) can succeed in an industry dominated by large, global organizations. Insights and analytics regarding CRO size, brand differentiation, talent development and customer service will be shared.
“Taking the time to discover and develop a sweet spot for your CRO can allow smaller players to take back market share,” said Monteleone. “During this session, we’ll explore some of the challenges as well as the opportunities that will allow small and midsized CROs to stay relevant.”
The summit brings together finance leaders and innovators from the pharmaceutical and health care industries. With greater focus on strategic collaborations, outsourcing, cost management and cost containment within these industries, the Pharma and Healthcare Summit is designed to create networking opportunities and will enable those who attend to share best practices and gain insights from executives, technologists, analysts and other senior-level professionals.
About Theorem Clinical Research
Theorem
Clinical Research Inc. is a leading midsized provider of
comprehensive clinical research and development services with offices in
more than 30 countries and a customer base comprised of some of the
world's top pharmaceutical, biotech and medical device companies. As a
forerunner in medical device and drug-device combination trials with
notable capabilities in pharmaceuticals and biologics, Theorem offers
deep expertise in a broad range of therapeutic areas and in all phases
of development. With some of the industry's top scientists and most
advanced clinical analytics capabilities, Theorem ensures
smooth-running, successful trials. For the full-service, right-size
global research partner, don't think twice. THINK THEOREM.
